Indeed, although the role of estrogens in the progression of ovarian cancer has been classically related only to their mitogenic effects on ERα-expressing tumor cells [8, 47], we here demonstrated that additional, tumor-promoting activity could involve host tissue, thus ultimately inducing the growth acceleration of ERα-negative ovarian cancer, as well. This evidence concerns the gene ESR1 and ovarian cancer.